Latest posts
-
GH Secretagogue Stack Research: CJC-1295 and Ipamorelin as a Dual-Mechanism Protocol
The CJC-1295 and ipamorelin combination is one of the most referenced dual-mechanism GH secretagogue protocols in research literature. This article examines the published pharmacological basis for GHRH and GHRP pathway synergy, why this specific pairing is commonly studied, and what the peer-reviewed literature does and does not establish about the combination.
-
IGF-1 LR3: Research on the Long-Acting Insulin-Like Growth Factor Analogue
IGF-1 LR3 (Long R3 IGF-1) is a synthetic analogue of human IGF-1 engineered with reduced IGF-binding protein affinity and extended half-life, making it a standard research tool for studying IGF-1 receptor signaling in cell culture and animal models. This overview covers its structural modifications, research applications, and distinction from approved IGF-1 therapeutics.
-
Ipamorelin: Research on the Selective Growth Hormone Secretagogue and Its Ghrelin Receptor Profile
Ipamorelin is a selective synthetic pentapeptide that stimulates GH release through the ghrelin receptor (GHS-R1a) without significantly elevating cortisol, ACTH, or prolactin — a selectivity profile that distinguishes it from earlier GHRPs. This research overview covers its mechanism, preclinical findings in GH axis and GI motility research, and published human clinical data.
-
CJC-1295: Research on the Long-Acting GHRH Analogue and Its Role in Growth Hormone Axis Studies
CJC-1295 is a synthetic GHRH analogue engineered with albumin-binding (DAC) technology to extend its half-life from minutes to approximately 6-8 days. This research overview covers its pharmacokinetic design, published phase 1 clinical data, its distinction from Modified GRF 1-29, and its context in GH axis research.
-
Tesamorelin: Research on the GHRH Analogue and Its Documented Applications in Clinical Science
Tesamorelin is a synthetic GHRH analogue with FDA approval for HIV-associated lipodystrophy — one of the few growth hormone-related peptides to complete full clinical development. This research overview covers its mechanism, regulatory history, pivotal trial data, and emerging research in metabolic and cognitive applications.
-
Growth Secretagogues: What Researchers Are Studying in the GH Axis
Growth hormone secretagogues work upstream of GH itself, stimulating the pituitary to release GH within natural pulsatile rhythms. This research overview covers CJC-1295, Ipamorelin, Tesamorelin, and IGF-1 LR3 — their mechanisms, research profiles, and how they differ. For research use only.
